

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
EW | NYSE | USD | Real-time | |
EW | Mexico | MXN | Delayed | |
EW | Frankfurt | EUR | Delayed | |
EW-RM | Moscow | RUB | Real-time |
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease.
Name | Age | Since | Title |
---|---|---|---|
Martha H. Marsh | 72 | 2015 | Lead Independent Director |
Michael A. Mussallem | 68 | 2000 | Chairman & CEO |
Leslie Stone Heisz | 61 | 2016 | Independent Director |
Ramona Sequeira | 56 | 2020 | Independent Director |
Paul A. LaViolette | 63 | 2020 | Independent Director |
Steven R. Loranger | 69 | 2016 | Independent Director |
Kieran T. Gallahue | 58 | 2015 | Independent Director |
Nicholas J. Valeriani | 64 | 2014 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review